These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 26349551)

  • 1. Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.
    Cao W; Mehraj V; Trottier B; Baril JG; Leblanc R; Lebouche B; Cox J; Tremblay C; Lu W; Singer J; Li T; Routy JP; ; Vézina S; Charest L; Milne M; Huchet E; Lavoie S; Friedman J; Duchastel M; Villielm F; Côté P; Potter M; Lessard B; Charron MA; Dufresne S; Turgeon ME; Rouleau D; Labrecque L; Fortin C; de Pokomandy A; Hal-Gagné V; Munoz M; Deligne B; Martel-Laferrière V; Gilmore N; Fletcher M; Szabo J
    Clin Infect Dis; 2016 Jan; 62(2):250-257. PubMed ID: 26349551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term antiretroviral therapy initiated during primary HIV-1 infection is key to achieving both low HIV reservoirs and normal T cell counts.
    Hocqueloux L; Avettand-Fènoël V; Jacquot S; Prazuck T; Legac E; Mélard A; Niang M; Mille C; Le Moal G; Viard JP; Rouzioux C;
    J Antimicrob Chemother; 2013 May; 68(5):1169-78. PubMed ID: 23335199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 control after transient antiretroviral treatment initiated in primary infection: role of patient characteristics and effect of therapy.
    Goujard C; Girault I; Rouzioux C; Lécuroux C; Deveau C; Chaix ML; Jacomet C; Talamali A; Delfraissy JF; Venet A; Meyer L; Sinet M;
    Antivir Ther; 2012; 17(6):1001-9. PubMed ID: 22865544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.
    Helleberg M; Kronborg G; Ullum H; Ryder LP; Obel N; Gerstoft J
    J Infect Dis; 2015 Jun; 211(11):1726-34. PubMed ID: 25489001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.
    Kaufmann GR; Furrer H; Ledergerber B; Perrin L; Opravil M; Vernazza P; Cavassini M; Bernasconi E; Rickenbach M; Hirschel B; Battegay M;
    Clin Infect Dis; 2005 Aug; 41(3):361-72. PubMed ID: 16007534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy.
    Ekwaru JP; Campbell J; Malamba S; Moore DM; Were W; Mermin J
    J Int AIDS Soc; 2013 Apr; 16(1):17355. PubMed ID: 23547778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
    Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
    Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.
    Jain V; Hartogensis W; Bacchetti P; Hunt PW; Hatano H; Sinclair E; Epling L; Lee TH; Busch MP; McCune JM; Pilcher CD; Hecht FM; Deeks SG
    J Infect Dis; 2013 Oct; 208(8):1202-11. PubMed ID: 23852127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8 T-Cell Expansion and Inflammation Linked to CMV Coinfection in ART-treated HIV Infection.
    Freeman ML; Mudd JC; Shive CL; Younes SA; Panigrahi S; Sieg SF; Lee SA; Hunt PW; Calabrese LH; Gianella S; Rodriguez B; Lederman MM
    Clin Infect Dis; 2016 Feb; 62(3):392-6. PubMed ID: 26400999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy.
    Seng R; Goujard C; Krastinova E; Miailhes P; Orr S; Molina JM; Saada M; Piroth L; Rouzioux C; Meyer L;
    AIDS; 2015 Mar; 29(5):595-607. PubMed ID: 25715104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.
    Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK;
    AIDS; 2015 May; 29(8):911-9. PubMed ID: 25730509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].
    Li H; Zheng YH; Shen Z; Liu M; Liu C; He Y; Chen J; Ou QY; Huang ZL
    Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(42):2973-6. PubMed ID: 18261327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ :  CD8+ ratio.
    Hughes RA; May MT; Tilling K; Taylor N; Wittkop L; Reiss P; Gill J; Schommers P; Costagliola D; Guest JL; Lima VD; d'Arminio Monforte A; Smith C; Cavassini M; Saag M; Castilho JL; Sterne JAC
    AIDS; 2018 Jun; 32(10):1361-1367. PubMed ID: 29851663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term and long-term clinical and immunological consequences of stopping antiretroviral therapy in HIV-infected patients with preserved immune function.
    Imaz A; Olmo M; Peñaranda M; Gutiérrez F; Romeu J; Larrousse M; Domingo P; Oteo JA; Curto J; Vilallonga C; Masiá M; López-Aldeguer J; Iribarren JA; Podzamczer D;
    Antivir Ther; 2013; 18(1):125-30. PubMed ID: 22805174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection.
    Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S;
    J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extent of HIV-1-related immunodeficiency and age predict the long-term CD4 T lymphocyte response to potent antiretroviral therapy.
    Kaufmann GR; Bloch M; Finlayson R; Zaunders J; Smith D; Cooper DA
    AIDS; 2002 Feb; 16(3):359-67. PubMed ID: 11834947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
    Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
    Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.
    Le T; Wright EJ; Smith DM; He W; Catano G; Okulicz JF; Young JA; Clark RA; Richman DD; Little SJ; Ahuja SK
    N Engl J Med; 2013 Jan; 368(3):218-30. PubMed ID: 23323898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Close association of CD8+/CD38 bright with HIV-1 replication and complex relationship with CD4+ T-cell count.
    Tuaillon E; Al Tabaa Y; Baillat V; Segondy M; Picot MC; Reynes J; Vendrell JP
    Cytometry B Clin Cytom; 2009 Jul; 76(4):249-60. PubMed ID: 19072838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.